Rsquared — Full Portfolio
4 tracked investments · listed companies and verified rows first
San Carlos, US
Frederic Moll(Executive Officer, Director)Frederic H. Moll(Executive Officer, Director)David Styka(Executive Officer)
BoardBijan Salehizadeh(Director)inAja Royan(Director)Peter Hebert(Director)
Board seatRobert Kerrey· per SEC Form D · $220M raise · filed Nov 2018
Co-investorsMithril Capital ManagementNaviMed Capital
Xtremity makes the XtremityTT, a thermoformable definitive prosthetic socket system built from an injection-molded, carbon-reinforced polymer preform that clinicians can heat, form, and assemble in about an hour and re-adjust via spot-heating.
HardwareHealthtechMedical DevicesNew MaterialsAspen, US
Mark Joseph(Founder / Inventor & Product Designer)Miguelangel Sosa(Executive Officer, Director)Amy Hill(Executive Officer)Scott Ward(Executive Officer)
Board seatRobert Kerrey· per SEC Form D · $10M raise · filed Jun 2019
Co-investorsDecheng CapitalARCH Venture Partners
Monolith produces carbon black using a thermal plasma hydrocarbon pyrolysis process, along with hydrogen and steam co-products used for energy.
Advanced ManufacturingCleantechNew MaterialsRedwood City, US
Peter L. Johnson(Executive Officer, Director)Robert J. Hanson(Executive Officer, Director)in
BoardJohannes Nieuwenburg(Director)Jason Montemurro(Director)Douglas Cameron(Director)JASON MONTEMURRO(Director)
Board seatRobert Kerrey· per SEC Form D · $120M raise · filed Jun 2021
Co-investorsAzimuth Capital ManagementWarburg PincusBlackRockTemasek
Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring.
Digital HealthHealthtechLongevityMedical DevicesWellness & FitnessBoston, US
Michael Dubrovsky(Co-Founder)inDiedrik Vermeulen(Founder)in
Co-investorsDuke Capital PartnersLongeVCNeer Venture PartnersOverlap HoldingsY CombinatorBalaji Srinivasan+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.